Roman Yelensky

Company: Gristone Bio

Job title: Executive Vice President & Chief Technology Officer

Seminars:

Evaluating Neoantigen Immunotherapies in the Clinic 12:00 pm

Utilizing advances in genomic analysis and interpretation for therapeutic development Selection of therapeutically useful neoantigens for immunization Integrating immune monitoring and cell free DNA (cfDNA) to evaluate immunotherapies clinicallyRead more

day: Track B - Day 2 AM